health biotech news today obesity drugs glp-1 Oral Pills for Weight Loss: How Orforglipron Works Novartis, Alector, Merck, Alnylm, UniQure

Impact of a Weekly Glucagon-Like Peptide 1 Receptor Agonist, Albiglutide, on Glycemic Control and on Reducing Prandial Insulin Use in Type 2 Diabetes Inadequately Controlled on Multiple Insulin Therapy: A Randomized Trial

A highly effective treatment for obesity and more The story doesnt stop there

Incretin-Based Therapies Twenty-seven years after the first publication by Nauck in Diabetologia [17], our understanding of the role of incretins in the pathophysiology of T2DM has made great advances [22]

It also slows digestion in the stomach

[53] Tirzepatide's efficacy for chronic weight management (weight reduction and maintenance) in combination with a reduced-calorie diet and increased physical activity was established in two randomized, double-blind, placebo-controlled trials in adults with obesity or overweight who had at least one weight-related condition

Patent term restoration for top-selling drugs in the United States